XML 18 R5.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ (25,665)   $ 2 $ 699 $ (26,366)
Beginning balance, shares at Dec. 31, 2019   6,712,085      
Beginning balance at Dec. 31, 2019   $ 30,960      
Beginning balance, Shares at Dec. 31, 2019     2,257,740    
Issuance of common stock upon exercise of stock options 198   $ 1 197  
Issuance of common stock upon exercise of stock options, shares     255,334    
Issuance of Series B redeemable convertible preferred stock, net of issuance costs   $ 17,466      
Issuance of Series B redeemable convertible preferred stock, net of issuance costs, shares   3,754,084      
Issuance of Series C redeemable convertible preferred stock   $ 58,677      
Issuance of Series C redeemable convertible preferred stock, shares   10,919,468      
Issuance of Series C redeemable convertible preferred stock upon conversion of notes payable and accrued interest   $ 13,978      
Issuance of Series C redeemable convertible preferred stock upon conversion of notes payable and accrued interest, shares   2,593,110      
Stock-based compensation 235     235  
Net loss (20,161)       (20,161)
Ending balance at Sep. 30, 2020 (45,393)   $ 3 1,131 (46,527)
Ending balance, Shares at Sep. 30, 2020   23,978,747      
Ending balance at Sep. 30, 2020   $ 121,081      
Ending balance, Shares at Sep. 30, 2020     2,513,074    
Beginning balance at Jun. 30, 2020 (33,746)   $ 2 969 (34,717)
Beginning balance, shares at Jun. 30, 2020   10,466,169      
Beginning balance at Jun. 30, 2020   $ 48,426      
Beginning balance, Shares at Jun. 30, 2020     2,444,904    
Issuance of common stock upon exercise of stock options 45   $ 1 44  
Issuance of common stock upon exercise of stock options, shares     68,170    
Issuance of Series C redeemable convertible preferred stock   $ 58,677      
Issuance of Series C redeemable convertible preferred stock, shares   10,919,468      
Issuance of Series C redeemable convertible preferred stock upon conversion of notes payable and accrued interest   $ 13,978      
Issuance of Series C redeemable convertible preferred stock upon conversion of notes payable and accrued interest, shares   2,593,110      
Stock-based compensation 118     118  
Net loss (11,810)       (11,810)
Ending balance at Sep. 30, 2020 (45,393)   $ 3 1,131 (46,527)
Ending balance, Shares at Sep. 30, 2020   23,978,747      
Ending balance at Sep. 30, 2020   $ 121,081      
Ending balance, Shares at Sep. 30, 2020     2,513,074    
Beginning balance at Dec. 31, 2020 $ (62,308) [1]   $ 3 1,403 (63,714)
Beginning balance, shares at Dec. 31, 2020 23,978,747 [1] 23,978,747      
Beginning balance at Dec. 31, 2020 $ 121,080 [1] $ 121,080      
Beginning balance, Shares at Dec. 31, 2020     2,712,694    
Conversion of redeemable convertible preferred shares into common stock 121,080   $ 24 121,056  
Conversion of redeemable convertible preferred shares into common stock, shares   (23,978,747)      
Conversion of redeemable convertible preferred shares into common stock   $ (121,080)      
Conversion of redeemable convertible preferred shares into common stock, shares     23,978,747    
Conversion of convertible notes into common stock 24,982   $ 2 24,980  
Conversion of convertible notes into common stock, shares     1,470,947    
Issuance of common stock upon IPO, net of issuance costs 159,898   $ 10 159,888  
Issuance of common stock upon IPO, net of issuance costs, shares     10,350,000    
Issuance of common stock upon exercise of stock options $ 516     516  
Issuance of common stock upon exercise of stock options, shares 440,055   440,055    
Issuance of common stock under Employee Stock Purchase Plan (ESPP) $ 332     332  
Issuance of common stock under Employee Stock Purchase Plan, shares     39,811    
Issuance of common stock for settlement of restricted stock units, Shares     11,250    
Stock-based compensation 6,500     6,500  
Net loss (57,012)       (57,012)
Ending balance at Sep. 30, 2021 $ 193,988   $ 39 314,675 (120,726)
Ending balance, Shares at Sep. 30, 2021 0        
Ending balance, Shares at Sep. 30, 2021     39,003,504    
Beginning balance at Jun. 30, 2021 $ 215,800   $ 39 308,991 (93,230)
Beginning balance, Shares at Jun. 30, 2021     38,684,546    
Issuance of common stock upon exercise of stock options 324     324  
Issuance of common stock upon exercise of stock options, shares     267,897    
Issuance of common stock under Employee Stock Purchase Plan (ESPP) 332     332  
Issuance of common stock under Employee Stock Purchase Plan, shares     39,811    
Issuance of common stock for settlement of restricted stock units, Shares     11,250    
Stock-based compensation 5,028     5,028  
Net loss (27,496)       (27,496)
Ending balance at Sep. 30, 2021 $ 193,988   $ 39 $ 314,675 $ (120,726)
Ending balance, Shares at Sep. 30, 2021 0        
Ending balance, Shares at Sep. 30, 2021     39,003,504    
[1] The balance sheet as of December 31, 2020 is derived from the audited financial statements as of that date